<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In both type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:e sem="disease" ids="C0271672" disease_type="Disease or Syndrome" abbrv="">diabetic complications</z:e> in target organs arise from <z:hpo ids='HP_0011010'>chronic</z:hpo> elevations of <z:chebi fb="105" ids="17234">glucose</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>The pathogenic effect of high <z:chebi fb="105" ids="17234">glucose</z:chebi>, possibly in concert with fatty acids, is mediated to a significant extent via increased production of reactive oxygen species (ROS) and reactive nitrogen species (<z:chebi fb="0" ids="33697">RNS</z:chebi>) and subsequent <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>ROS and <z:chebi fb="0" ids="33697">RNS</z:chebi> directly oxidize and damage DNA, proteins, and <z:chebi fb="23" ids="18059">lipids</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>In addition to their ability to directly inflict damage on macromolecules, ROS and <z:chebi fb="0" ids="33697">RNS</z:chebi> indirectly induce damage to tissues by activating a number of cellular stress-sensitive pathways </plain></SENT>
<SENT sid="4" pm="."><plain>These pathways include nuclear factor-kappaB, p38 <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase, NH(2)-terminal Jun kinases/stress-activated protein kinases, <z:chebi fb="0" ids="24586">hexosamines</z:chebi>, and others </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, there is evidence that in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, the activation of these same pathways by elevations in <z:chebi fb="105" ids="17234">glucose</z:chebi> and free fatty acid (FFA) levels leads to both <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:e sem="disease" ids="C0948379" disease_type="Disease or Syndrome" abbrv="">impaired insulin secretion</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Therefore, we propose here that the <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>-induced, and possibly FFA-induced, activation of stress pathways plays a key role in the development of not only the late complications in type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, but also the <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:e sem="disease" ids="C0948379" disease_type="Disease or Syndrome" abbrv="">impaired insulin secretion</z:e> seen in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>